User login
On July 12, the FDA’s Division of Drug Information will host a webinar at 1 pm ET and will offer one hour of continuing education credit. The topic will be the Expanded Access process, through which patients may obtain access to investigational therapies and a new patient application recently published by FDA.
On July 12, the FDA’s Division of Drug Information will host a webinar at 1 pm ET and will offer one hour of continuing education credit. The topic will be the Expanded Access process, through which patients may obtain access to investigational therapies and a new patient application recently published by FDA.
On July 12, the FDA’s Division of Drug Information will host a webinar at 1 pm ET and will offer one hour of continuing education credit. The topic will be the Expanded Access process, through which patients may obtain access to investigational therapies and a new patient application recently published by FDA.
